Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Impax Laboratories Inc. (IPXL)

NASDAQ: Health Care

Get a 5-page Ratings Report on (IPXL) now
$18.82 0.31 | 1.67%
Today's Range: 18.46 - 18.87
IPXL Avg. Daily Volume: 1,261,900
05/22/13 - 11:55 AM ET
  • Latest Dividend: N/A
  • Latest Dividend Yield: N/A
  • Dividend Ex-Date: N/A
  • Price Earnings Ratio: 8.42
  • Price Earnings Comparisons:
    IPXL Sector Avg. S&P 500
    8.42 8.50 17.70
  • Price Performance History
    (% change):
    3 Mo 1 Yr 3 Yr
    -6.21% -11.73% -6.21%
  • GROWTH 12 Mo 3 Yr CAGR
    Revenue 13.40 0.62 0.17
    Net Income -14.70 0.12 0.04
    EPS -15.50 0.02 0.01
  • Earnings for IPXL:
    EBITDA 171,956,000
    REVENUE 581,692,000
Average Earnings Estimates
Qtr (06/13) Qtr (09/13) FY (12/13) FY (12/14)
Average Estimate $0.02 $-0.10 $0.16 $0.57
Number of Analysts 7 6 8 8
High Estimate $0.06 $-0.03 $0.50 $0.99
Low Estimate $-0.03 $-0.17 $-0.07 $0.38
Prior Year $0.60 $0.48 $1.91 $0.16
Growth Rate (Year over Year) -96.19% -121.18% -91.56% 251.94%
(IPXL) News

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 15,502.69 115.11 0.75%
NASDAQ 3,521.58 19.46 0.56%
S&P 500 1,680.95 11.79 0.71%
US 10 Yr 1.988% +0.044

Brokerage Partners

Advertising Partners

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.

Top Rated Stocks Top Rated Funds Top Rated ETFs